← Leaderboards
John Kyung Lee
Fred Hutchinson Cancer Research Center
$4,285,148
Attributed
$4,285,148
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.2M · FY2021–25$2.5M$1.9M$1.3M$625K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,285,148 · 2
By mechanism
DP2$3,440,386 · 1
P50$844,762 · 1
Top collaborators
No co-investigators on record.
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- Joshi James Alumkal$6,560,072
- David F Penson$16,023,274
- Gavin Ha$4,673,787
- Elahe A Mostaghel$1,491,129
- Janet L Stanford$12,426,000
Others in their field
Other Emerging Leaders on “Malignant Neoplasms”
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
- Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Martha Hering · Westat, Inc.$57,098,843
Research focus
Malignant NeoplasmsInsightMalignant Neoplasm Of ProstateProstateGeneticBiologicalPhenotypeProstate Cancer ModelEvolutionCellsAdoptive Cell TransfersAntigensAntigen-Specific T CellsBar CodesCancer GenomicsAntigen PresentationAffectCancer VaccinesAndrogen ReceptorCancer BiologyCancer EtiologyAndrogensAdvanced Prostate CancerCar T Cell Therapy
Grant awards (8)
Project 3: Modulating Androgen Receptor Signaling to Enhance the Efficacy of CAR T Cell Therapy for Advanced Prostate Cancer$237,841
P50 · FY2025 · CA · contact PI
Uncovering diverse genotype-phenotype relationships in prostate cancer$945,000
DP2 · FY2024 · CA · contact PI
Project 3: Modulating Androgen Receptor Signaling to Enhance the Efficacy of CAR T Cell Therapy for Advanced Prostate Cancer$280,372
P50 · FY2024 · CA · contact PI
Project 3: Modulating Androgen Receptor Signaling to Enhance the Efficacy of CAR T Cell Therapy for Advanced Prostate Cancer$326,549
P50 · FY2023 · CA · contact PI
Diversity Supplement: Uncovering diverse genotype-phenotype relationships in prostate cancer$268,726
DP2 · FY2022 · CA · contact PI
Uncovering diverse genotype-phenotype relationships in prostate cancer$1,419,627
DP2 · FY2021 · CA · contact PI
Uncovering diverse genotype-phenotype relationships in prostate cancer$642,660
DP2 · FY2021 · CA · contact PI
Uncovering diverse genotype-phenotype relationships in prostate cancer$164,373
DP2 · FY2021 · CA · contact PI